Recent Price Movement and Market Comparison
Jubilant Ingrevia’s stock has underperformed both its sector and broader market indices in recent periods. Over the past week, the share has declined by 5.33%, significantly more than the Sensex’s modest 0.94% drop. The one-month and year-to-date returns are also weak, with losses exceeding 10%, compared to the Sensex’s declines of less than 1% and 2.3% respectively. Even over the last year, the stock’s gain of 0.30% pales in comparison to the Sensex’s 9.66% rise, highlighting a persistent lag in performance.
On the day in question, the stock touched an intraday low of ₹622.65, down nearly 3%, and traded below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This technical weakness signals a bearish sentiment among traders and investors, further contributing to the downward pressure on the share price.
Investor participation has also waned, with delivery volumes on 13 Feb falling by almost 52% compared to the five-day average. This reduced trading activity suggests a cautious stance among shareholders, possibly reflecting uncertainty about the company’s near-term prospects.
Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!
- - Recently turned profitable
- - Strong business fundamentals
- - Pre-breakout opportunity
Fundamental Strengths Amidst Challenges
Despite the recent price weakness, Jubilant Ingrevia exhibits some positive financial attributes. The company maintains a strong ability to service its debt, with a low Debt to EBITDA ratio of 1.20 times, indicating manageable leverage. Its return on capital employed (ROCE) stands at a respectable 10.6%, and the enterprise value to capital employed ratio of 2.8 suggests the stock is attractively valued relative to its peers.
Profitability has shown improvement over the past year, with profits rising by 33.2%, even as the stock’s price has remained largely flat. The company’s PEG ratio of 1.1 further indicates that its valuation is reasonable in relation to its earnings growth. Institutional investors hold a significant 30.17% stake in the company, and their shareholding increased by 1.15% in the previous quarter, signalling confidence from more sophisticated market participants.
Lingering Concerns Over Growth and Profitability
However, the company’s longer-term growth trajectory raises concerns. Over the past five years, net sales have declined at an annual rate of 0.45%, while operating profit has contracted sharply by 13.67% annually. The most recent quarterly profit after tax (PAT) of ₹56.25 crores fell by 21.9% compared to the average of the previous four quarters, indicating a weakening earnings trend.
Operational efficiency metrics also point to challenges. The debtors turnover ratio is low at 5.56 times, suggesting slower collection cycles, and the operating profit to interest coverage ratio stands at a modest 10.16 times, the lowest recorded, which may raise concerns about the company’s ability to comfortably cover interest expenses in tougher conditions.
These fundamental weaknesses have contributed to the stock’s underperformance relative to the broader market, with a one-year return of just 0.30% compared to the BSE500’s 13.31% gain. The combination of subdued sales growth, declining profitability, and technical weakness has weighed heavily on investor sentiment, driving the recent price decline.
Holding Jubilant Ingrev. from Specialty Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Conclusion: A Stock Under Pressure Despite Some Positives
In summary, Jubilant Ingrevia Ltd’s share price decline as of 16-Feb is primarily driven by its recent weak price performance, technical indicators signalling bearish momentum, and investor caution reflected in falling volumes. While the company benefits from a strong debt servicing capacity, attractive valuation metrics, and rising profits over the past year, these positives are overshadowed by poor long-term sales growth, declining operating profits, and a recent drop in quarterly earnings.
Investors appear to be factoring in these mixed signals, resulting in the stock’s underperformance relative to the broader market and sector peers. Until the company demonstrates a sustained turnaround in growth and profitability, the downward pressure on its share price is likely to persist.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
